Loading…
UNCY · NASDAQ · Pharmaceutical Preparations
Pharmaceutical Preparations company based in Mountain View, Ca.
In the last 90 days, no insider of Unicycive Therapeutics reported an open-market purchase and 0 open-market sales. Every figure links to its official SEC, House, Senate or USAspending record.
Last closeLast close, Oct 6, 2026
$4.23
Last 12 months
Not enough history
Market value
$118M
Revenue
—
Free cash flow, last 12 months
−$27.8M
This quarter −$7.6M, a year earlier −$8.43M
Net debt
—
Debt —, cash $44.2M, at Jun 30, 2026
Net income, last 12 months
−$35.2M
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Aug 12, 2026.
Insiders buying, last 90 days
None
No open-market purchases reported
Insiders selling, last 90 days
None
No open-market sales reported
New federal contracts, 12 months
None
Nothing found for this company
Nothing reported yet
New filings show up here as soon as they are processed.
Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.